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In sub-Saharan Africa, presentation with 
chronic hepatomegaly (HM) that usually has 
a firm to hard consistency upon palpation is 
common among school-age children (Gryseels 
1988). Enlargement of the liver can be exten-
sive and associated with accompanying enlarge-
ment of the spleen [splenomegaly (SM)], which 
is also of a firm to hard consistency upon palpa-
tion (Fulford et al. 1991). Long-term health 
outcomes of this condition are yet to be defined, 
but it is likely to have an adverse impact on 
health. It is associated with increases in portal 
pressure (Vennervald et al. 2004), and recent 
analysis suggested an association with slowed 
child growth (Wilson et al. 2010). Chronic 
hepatosplenomegaly (HSM) has a complex eti-
ology of a multifactorial nature. Among school-
age children in Makueni District, Kenya, where 
chronic HSM is highly prevalent, chronic 
exposure to malaria infection has been shown 
to be associated with HSM, with a particu-
larly strong association with enlargement of the 
spleen being observed (Mwatha et al. 2003; 
Wilson et al. 2007b). It has also been shown 
that concurrent Schistosoma mansoni infection 
exacerbates this underlying HSM (Booth et al. 
2004b; Wilson et al. 2007b). Although these 
two infections appear to contribute to HSM, 
less than satisfactory resolution after treatment 
of the infections suggests that other etiological 
factors may contribute to the HM observed in 
these children.
Aflatoxin, a secondary metabolite produced 
by Aspergillus species, is a liver toxicant and a 
known human liver carcinogen (International 
Agency for Research on Cancer 2002). The 
hot and humid weather in sub-Saharan Africa 
is favorable to fungal growth and aflatoxin 
production. Aflatoxin exposure has been con-
sistently found at high levels in sub-Saharan 
African populations because of consumption 
of highly contaminated food such as maize and 
groundnuts (Wild and Gong 2010). Many 
children are chronically exposed to high levels 
of aflatoxin through diet, and the exposure is 
associated with child growth impairment in 
West Africa (Gong et al. 2002, 2003, 2004). 
The consequences of such early-life exposure 
merits more investigation to assess the full 
extent of the impact on child health.
High levels of contamination and expo-
sure to aflatoxin have been reported in Kenya, 
including in the Makueni District (Lewis et al. 
2005; Mwihia et al. 2008; Ngindu et al. 1982). 
One outbreak occurred in 1981 (Ngindu et al. 
1982), during which 20 patients with jaundice 
were hospitalized and 12 died of hepatic fail-
ure because of consumption of maize heavily 
contaminated with aflatoxin. In 2004, 317 
cases of acute hepatic failure due to ingestion 
of highly aflatoxin-contaminated locally grown 
maize, including 125 deaths, were reported 
across several districts, including Makueni 
(Azziz-Baumgartner et al. 2005; Strosnider 
et al. 2006). The aflatoxin level in the market 
maize samples was up to 46,400 ppb, more 
than a thousand-fold higher than the regu-
lated 20-ppb maximum limit in food; 65% of 
the maize samples from Makueni were above 
the 20-ppb limit (Lewis et al. 2005). At the 
same time, levels of  aflatoxin–albumin adducts 
(AF-alb), an aflatoxin exposure biomarker, 
were the highest ever reported (McCoy et al. 
2008; Wild and Gong 2010), ranging up to 
67,000 pg/mg albumin.
Here we provide a preliminary analysis 
of the association between HM and aflatoxin 
exposure during 2002 and 2004 in a cohort of 
school-age children living in Makueni District.
Methods
Study area and population. Makueni District 
is characterized by seasonal rains typically fall-
ing in November–December and April–May. 
The study population was based in two neigh-
boring village schools: Matangini Primary in 
Lower Mangelete in the east, and Yumbuni 
Primary in the west. Lower Mangelete has a 
series of permanent streams and irrigational 
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Background: Presentation with a firm type of chronic hepatomegaly of multifactorial etiology is 
common among school-age children in sub-Saharan Africa. 
oBjective: Aflatoxin is a liver toxin and carcinogen contaminating staple maize food. In this study 
we examined its role in chronic hepatomegaly. 
Methods: Plasma samples collected in 2002 and again in 2004 from 218 children attending two 
schools in neighboring villages were assayed for aflatoxin exposure using the aflatoxin-albumin 
adduct (AF-alb) biomarker. Data were previously examined for associations among hepatomegaly, 
malaria, and schistosomiasis.
results: AF-alb levels were high in children from both schools, but the geometric mean (95% con-
fidence interval) in year 2002 was significantly higher in Matangini [206.5 (175.5, 243.0) pg/mg 
albumin] than in Yumbuni [73.2 (61.6, 87.0) pg/mg; p < 0.001]. AF-alb levels also were higher in 
children with firm hepatomegaly [176.6 (129.6, 240.7) pg/mg] than in normal children [79.9 (49.6, 
128.7) pg/mg; p = 0.029]. After adjusting for Schistosoma mansoni and Plasmodium infection, we 
estimated a significant 43% increase in the prevalence of hepatomegaly/hepatosplenomegaly for 
every natural-log-unit increase in AF-alb. In 2004, AF-alb levels were markedly higher than in 2002 
[539.7 (463.3, 628.7) vs. 114.5 (99.7, 131.4) pg/mg; p < 0.001] but with no significant difference 
between the villages or between hepatomegaly and normal groups [539.7 (436.7, 666.9) vs. 512.6 
(297.3, 883.8) pg/mg], possibly because acute exposures during an aflatoxicosis outbreak in 2004 
may have masked any potential underlying relationship. 
conclusions: Exposure to aflatoxin was associated with childhood chronic hepatomegaly in 2002. 
These preliminary data suggest an additional health risk that may be related to aflatoxin exposure in 
children, a hypothesis that merits further testing.
key words: aflatoxicosis outbreak, aflatoxin, aflatoxin albumin adducts, biomarker, child health, 
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canals, whereas surface water in Yumbuni is 
mainly seasonal. The main dietary staples in the 
population are the maize-based dishes githeri 
and ugali. A detailed description of the study 
area is given elsewhere (Wilson et al. 2007a).
We conducted a cross-sectional school-
based study in May–June 2002, including all 
children 6–17 years of age who were attend-
ing the Matangini (n = 228) and Yumbuni 
(n = 221) primary schools at the time of the 
study. Most of the children attended their 
local village school, so we use the name of the 
school attended (Matangini and Yumbuni) to 
represent the village in which the child lived. 
A few children attending the schools who were 
> 17 years old were excluded from the study.
In all children, malaria infection was 
determined by parasitological techniques, 
including measurement of parasitemia and 
Plasmodium falciparum schizont antigen IgG3 
(Pfs-IgG3) levels, a marker of chronic expo-
sure to Plasmodium infections (Wilson et al. 
2007a). Schistosomiasis was diagnosed based 
on the S. mansoni egg count from three separate 
stool samples, using the Kato Katz technique; 
two slides were prepared from each sample, as 
described elsewhere (Wilson et al. 2007b).
A subset of 249 children was randomly 
selected for ultrasound examination and blood 
sampling in 2002 and with a repeat examina-
tion in 2004. AF-alb levels were measured 
for all children in this subset except a small 
number of individuals (n = 31) whose blood 
samples were exhausted in previous immuno-
logical assays that had been applied to all 
children in the subset. Age, sex, and health 
were not significantly different between the 
wider cohort and the subset of children (data 
not shown).
Informed consent was obtained from the 
parents or guardians. Ethics approval was 
obtained from the Kenya Medical Research 
Institute Ethical Review Committee.
Clinical examination. All children were 
examined for enlarged livers and spleens by 
palpation by three clinicians in 2002 and 2004, 
and a consensus among the clinicians had to 
be achieved before assigning the child to an 
organomegaly group, as previously described 
(Wilson et al. 2007b). The liver and/or spleen 
was considered enlarged if it was palpable 
> 2 cm below the costal line. The children 
were initially classified into five categories: no 
organo megaly, soft liver or spleen enlargement, 
firm to hard spleen enlargement (SM), firm to 
hard liver enlargement (HM), and both firm to 
hard liver and spleen enlargement (HSM).
Blood AF-alb measurements. Plasma sam-
ples collected from the 218 children examined 
in both 2002 and 2004 underwent AF-alb 
analysis in 2009. The blood AF-alb levels were 
determined using an enzyme-linked immuno-
sorbent assay (ELISA) after albumin extrac-
tion from 250 μL plasma, digestion, and 
purification as previously described (Chapot 
and Wild 1991). One negative and three 
posi tive controls were analyzed alongside each 
batch of samples. Samples were measured 
using ELISA in quadruplicate on at least two 
occasions on separate days. The detection 
limit was 3 pg AF-alb per 1 mg albumin.
Statistical analyses. AF-alb data is not 
normally distributed and was therefore 
natural-log-transformed before data analy-
sis. Geometric mean AF-alb levels and 95% 
confidence intervals (CIs) are presented 
unless otherwise stated. Student’s t-test and 
analysis of variance (ANOVA) were used for 
comparing levels between groups. Chi-square 
test was used for categorical variables distri-
bution test. Pearson’s correlation coefficients 
were calculated for the association between 
continuous variables. Logistic regression mod-
els were constructed to estimate odds ratios 
for groupings of HM in association with afla-
toxin exposure adjusted for schistosomiasis 
and malaria, which are known confounders or 
modifiers. Statistical analyses were carried out 
using STATA (version 9; StataCorp, College 
Station, TX, USA). A p-value < 0.05 was used 
to define statistical significance.
Results
Description of the study cohort. Table 1 sum-
marizes the key variables of the 124 and 94 
children 6–17 years of age from Yumbuni 
and Matangini. There were no significant 
differences in mean age or sex ratio between 
the two schools. Malaria and schistosomiasis 
were prevalent in this region. In 2002, the 
prevalence of schistosomiasis in these children 
was significantly higher in Matangini than in 
Yumbuni (70% vs. 8%, p < 0.001). There was 
no significant difference in the prevalence of 
malaria based on the presence of parasitemia 
(27% vs. 18%, p = 0.159) or the Pfs-IgG3 
marker of exposure [optical density (OD) 
value, 0.47 vs. 0.44; p = 0.106] between chil-
dren attending the two schools.
Aflatoxin exposure. Plasma AF-alb  levels were 
not correlated with the children’s age or sex. 
The geometric mean AF-alb level for children 
in Matangini was significantly higher than that 
of children in Yumbuni [206.5 pg/mg (175.7, 
243.0) vs. 73.2 pg/mg (61.6, 87.0) pg/mg; 
p < 0.001] in 2002 (Table 1). During 2004, 
AF-alb mean levels were significantly higher 
than in 2002 in both villages [combined means 
of 539.7 pg/mg (463.3, 628.7) in 2004 vs. 
114.5 pg/mg (99.7, 131.4) in 2002; p < 0.001], 
but there was no longer a significant difference 
in the means between the two villages.
AF-alb levels were not associated with 
malaria parasitemia or correlated with Pfs-IgG3 
levels. Children with S. mansoni infection had 
more than double the AF-alb level as those 
without in 2002. However, the difference 
became non significant after data were adjusted 
for village. There was no significant association 
between S. mansoni infection and AF-alb in 
2004 (data not shown).
Prevalence of HM. The prevalence of 
HM/HSM was not significantly different 
between Yumbuni and Matangini in 2002 
(73% vs. 76%; p = 0.686) or 2004 (74% vs. 
83%; p = 0.087). There was no significant 
difference in HM prevalence between the 
subset and the wider group of the cohort 
(data not shown).
The number of children with HM only 
was 48 in year 2002, but this increased to 104 
in 2004 (Table 2). Most children (88%) who 
Table 1. Description of the cohort in 2002 (except as specified).
School
Variable Yumbuni Matangini Total
n 124 94 218
Age [years (mean ± SD)] 11.6 ± 3.0 12.5 ± 2.8 12.0 ± 2.9
Male:female ratio 1:1 1:1 1:1
Malaria prevalence 20/109 (18%) 24/90 (27%) 44/199 (22%)
S. mansoni prevalence  10/124 (8%) 66/94 (70%)* 76/218 (35%)
Pfs-IgG3 [OD (mean ± SD)] 0.44 ± 0.15 0.47 ± 0.13 0.45 ± 0.10
AF-alb [geometric mean (95% CI)]
2002  73.2 (61.6, 87.0) 206.5 (175.5, 243.0)* 114.5 (99.7, 131.4)
2004 578.5 (466.4, 717.6) 492.0 (397.3, 609.2) 539.7 (463.3, 628.7)
*p ≤ 0.001 compared with Yumbuni. 
Table 2. AF-alb (pg/mg) in different organomegaly groups in 2002 and 2004 [geometric mean (95% CI)].
2002 2004
Organomegaly group na AF-alb na AF-alb
Normal 21 79.9 (49.6, 128.7)* 35 512.6 (297.3, 883.8)
Soft organomegaly 13 57.5 (27.7, 119.2)* 2 452.9b
SM 21 102.6 (65.4, 160.8) 12 604.3 (332.9, 1096.7)
HM 48 176.6 (129.6, 240.7) 104 539.7 (436.7, 666.9)
HSM 112 108.0 (90.5, 129.0) 63 533.7 (416.4, 684.0)
aThree children in 2002 and one child in 2004 were not classifiable into one of the clinical groups, and one child in 2004 
had missing AF-alb data; they were all excluded. bThere is no CI because only two children were in this group. *p < 0.05 
compared with the HM group by ANOVA.
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had HM/HSM in 2002 still had HM/HSM 
in 2004. Most new HM cases in 2004 had 
been classified as HSM cases in 2002 but had 
resolution of their SM. The total number of 
children with HM/HSM did not vary signifi-
cantly between 2002 and 2004 (160 vs. 167).
There was no significant relationship 
between the presentation of organomegaly 
and the age or the sex of the children in 2002 
(data not shown). However, in 2004 children 
with HM/HSM (mean age, 11.5 years) were 
younger than normal children and children 
with SM (mean age, 13.5 years), whereas the 
two children with soft organomegaly were the 
youngest in the group (mean age, 6.5 years). 
More girls were in the normal group than 
boys in 2004 (22% vs. 12%; p = 0.041).
Aflatoxin exposure and organomegaly. 
In 2002, the geometric mean AF-alb level 
was significantly higher in children with HM 
than in children without firm organomegaly 
(Table 2)—that is, children classified as nor-
mal or with soft organomegaly (p = 0.029 
and 0.004, respectively). No significant dif-
ference in geometric mean AF-alb levels was 
found among HM, SM, and HSM groups 
[176.6 pg/mg (129.6, 240.7), 102.6 pg/mg 
(65.4, 160.8), and 108.0 pg/mg (90.5, 129.0), 
respectively]. For samples collected in 
2004, AF-alb levels were markedly high in 
all groups, and no significant difference in 
AF-alb levels was observed between children 
with HM and any other groups.
After adjusting for S. mansoni infection 
and Pfs-IgG3 quartiles, which had previously 
been shown to be associated with HSM in the 
wider cohort, there was a 43% increase in the 
prevalence of HM/HSM versus non-HM for 
each natural log unit increase in AF-alb (odds 
ratio = 1.43; 95% CI: 1.04, 1.97) (Table 3).
Discussion
Childhood HSM in sub-Saharan Africa is 
likely to be of a complex multifactorial etiol-
ogy. In the present study, samples collected 
during a previous study among school-age 
children in 2002 and at follow-up in 2004 
were used to examine associations between 
HSM and aflatoxin exposure using the AF-alb 
biomarker.
The AF-alb biomarker has a relatively 
long half-life (1–2 months) compared with 
other aflatoxin biomarkers. It is well accepted 
to be a reliable marker in aflatoxin exposure 
assessment and has been applied to studies 
of chronic diseases (Wild and Gong 2010), 
including carcinogenesis, and growth retar-
dation and immune-suppression effects in 
young children (Gong et al. 2002, 2004; 
Wild and Gong 2010). The biomarker has 
been repeatedly applied in retrospective type 
studies (Wild, and Gong 2010) and there is 
no evidence that this biomarker is liable to 
degradation in stored plasma samples.
Compared with exposure in other popula-
tions in sub-Saharan Africa (Wild and Gong 
2010), aflatoxin exposure was already high 
in 2002, especially in Matangini, with the 
exposure level nearly triple that of children 
from Yumbuni. Initial analysis in 2002 indi-
cated that there was a significant association 
between increased exposure to aflatoxin and 
S. mansoni infection, with S. mansoni infec-
tion being more prevalent and AF-alb levels 
being elevated in Matangini compared with 
Yumbuni. The presence of permanent sur-
face water makes Matangini more humid 
than Yumbuni and hence more favorable to 
fungal growth and aflatoxin production com-
pared with Yumbuni. The permanent streams 
and irrigation canals in Matangini also pro-
vide a habitat for Biomphalaria species, the 
aquatic snail that is the intermediate host of 
S. mansoni, whereas the lack of permanent sur-
face water abrogates transmission in Yumbuni. 
The association between S. mansoni infection 
and AF-alb levels is therefore likely attribut-
able to environmental conditions in Matangini 
being more favorable than in Yumbuni for 
both S. mansoni transmission and growth of 
Aspergillus species. This is substantiated by the 
reduced magnitude of association when com-
paring AF-alb levels between children with or 
without S. mansoni infection when adjusted 
for location. However, the biologically plau-
sible hypothesis that aflatoxin exposure may 
induce chronic liver damage, which increases 
the susceptibility to schistosomiasis- associated 
morbidity—or vice versa, that the liver dam-
age due to schistosomiasis infection may 
alter the metabolism of aflatoxin and also the 
synthesis of albumin, which could affect the 
AF-alb level—merits further analysis in studies 
designed to address this question.
In contrast to a previous report (Allen 
et al. 1992), the AF-alb level did not differ 
significantly between children with or with-
out malaria parasitemia, nor was it associated 
with the chronic malaria marker Pfs-IgG3 in 
the present study. Future study on the direct 
relationship between aflatoxin exposure and 
malaria is required.
The AF-alb levels were exceptionally high 
in 2004—in fact the highest ever reported—
and the difference between villages was not 
observed. This exceptional level is consistent 
with the widely reported aflatoxicosis out-
break in 2004 in Kenya when AF-alb lev-
els were the highest ever published (McCoy 
et al. 2008). The reason for the outbreak was 
consumption of home-grown maize that was 
highly contaminated with aflatoxin because 
of both the drought stress and being stored 
at warmer indoor conditions after the poor 
harvest, to prevent theft (Azziz-Baumgartner 
et al. 2005). It was also reported that the con-
taminated home-grown maize was sold in the 
local market and was bought by farmers after 
their home-grown supplies were exhausted, 
resulting in widespread distribution of the 
contaminated maize (Lewis et al. 2005). 
Village location played a less significant role 
in the AF-alb levels during the outbreak.
Aflatoxin is a liver toxin in several animal 
species (International Agency for Research on 
Cancer 2002). It causes liver enlargement in 
broiler chickens (Kumar and Balachandran 
2009; Mani et al. 2000) and in animals suf-
fering aflatoxicosis (Gonzalez Pereyra et al. 
2008; Osman et al. 2004). To our knowledge 
there are no previous reports of chronic HM 
occurrence in chronically exposed humans. 
In 2002, the AF-alb levels were significantly 
higher in children with HM than in those 
without firm organomegaly, indicating that 
aflatoxin exposure may play an important 
role in HM occurrence. The non significant 
difference in the AF-alb level between HSM 
and other groups suggests that the etiology 
of HSM may be even more complex than 
HM, so contribution by aflatoxin exposure 
could be diluted. For example, the effect of 
malaria exposure is greater on the spleen than 
on the liver, and vice versa for schistosomia-
sis, and there is evidence that both infections 
contribute to enlargement of both organs 
(Wilson et al. 2007b). After controlling for 
S. mansoni and Plasmodium infection, there 
was an association between aflatoxin and HM, 
with the prevalence of having HM (including 
HSM) being increased by 43% in association 
with a natural-log-unit increase in AF-alb. 
The mechanism needs further elucidation, 
although compromised liver function and the 
subsequent changes in liver metabolism due 
to chronic exposure to aflatoxin may contrib-
ute to HM development.
S. mansoni infection status and Pfs-IgG3 
were not significantly associated with HM/
HSM in the logistic model that also included 
AF-alb. In the wider cohort, S. mansoni was 
associated with an increase in the size of the 
liver, suggesting this infection could exacer-
bate the condition, but there was no statisti-
cally significant association with prevalence of 
HM (Wilson et al. 2007b). Also in the wider 
cohort, increased exposure to Plasmodium 
infection did show a weak association with 
HM only, but the levels of the Pfs-IgG3 were 
not elevated in HM as much as in HSM 
(Wilson et al. 2007b). In a previous study 
in Makueni District, annual treatment of 
S. mansoni infections and regular molluscid-
ing of the River Kambu (the habitat for the 
Table 3. Logistic regression model for HM/HSM 
in 2002.
Variable Odds ratio (95% CI) p-Value
ln(AF-alb) 1.43 (1.04, 1.97) 0.030
S. mansoni infectiona 1.58 (0.73, 3.40) 0.241
Pfs-IgG3 1.20 (0.90, 1.60) 0.215
aAs determined by the presence of detectable eggs.
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intermediate host) over a 3-year period did 
not achieve complete resolution of childhood 
HM (Vennervald et al. 2005). In that study 
the children who lived close to the river and 
had the highest levels of Pfs-IgG3 had the 
poorest resolution of their HM (Booth et al. 
2004a). All this evidence suggests that the 
HM/HSM observed in these children is of 
a chronic complex nature and may also be 
reversible in a slow process.
During the interim period between the 
2002 and 2004 examinations, there was a sub-
stantial increase in HM cases, largely due to a 
shift from HSM to HM—in other words, a 
reduction in SM cases. These represent indi-
vidual children whose condition changed from 
HSM to HM during the 2-year period; that is, 
the HM status persisted, showing that this was 
a chronic condition in these children, whereas 
SM was reversed. The reduction in SM cases 
may possibly be explained by reduced malaria 
transmission due to the drought that was asso-
ciated with the acute aflatoxin outbreak in 
2004, which would also have had a signifi-
cant impact on the seasonal transmission of 
malaria, as evidenced by a drop in Pfs-IgG3 
levels (Wilson S, unpublished observations).
The aflatoxicosis outbreak in 2004 resulted 
in extremely high levels of AF-alb in most 
of the children, and there was no significant 
association between AF-alb and HM/HSM in 
2004. It is possible that this lack of association 
in 2004 between HM and AF-alb may result 
from the high acute exposure during the afla-
toxicosis outbreak masking any putative under-
lying relationship between aflatoxin exposure 
and chronic HM. It does not in itself negate 
the potential association between the two, but 
it is recognized that the association observed 
in 2002 may be a false positive and therefore 
requires investigation in other studies.
A large-scale association study is now desir-
able, specifically designed to address the role of 
aflatoxin in HM and taking account of the 
role of infections. Alternatively, an interven-
tion study, if feasible, would provide the best 
approach to draw a conclusion about the etio-
logical association between HM and aflatoxin 
exposure. Nevertheless, the present study high-
lights a potential new health effect of aflatoxin 
exposure. This further emphasizes the need 
for education to improve public awareness of 
aflatoxin-associated health risks and for the 
development of effective aflatoxin prevention 
strategies. It is worth noting that the need for 
intervention has already been identified in this 
region of Kenya and is being put into practice, 
which may have contributed to the reduced 
severity of the 2010 aflatoxicosis outbreak.
Conclusion
This study raises the possibility of an asso-
ciation between aflatoxin exposure and child-
hood HM, at least at exposure levels that do 
not induce acute aflatoxicosis. This finding 
provides the first evidence pointing to this 
health effect of these liver toxicants. This 
observation merits further study in other areas 
of high aflatoxin exposure, in studies designed 
to directly test this hypothesis.
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